Evidence map›Paper›PMID 38695519›Full record

ArticleApplied and environmental microbiology2024

Multidrug resistance in

V Garrido, A Arrieta-Gisasola, L Migura-García, L Laorden, M J Grilló

Open access · greenAbstract read
In one paragraph

Article in Applied and environmental microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Emergence ofFrontiers in microbiology · 2026
    Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

V Garrido *Instituto de Agrobiotecnología (IdAB; CSIC-Gobierno de Navarra), Mutilva, Navarra, Spain.ORCID 0000-0002-2497-7188
A Arrieta-Gisasola *Department of Immunology, Microbiology and Parasitology, Faculty of Pharmacy, MikroIker Research Group, University of the Basque Country (UPV/EHU), Vitoria-Gasteiz, Spain.ORCID 0000-0002-6406-8165
L Migura-GarcíaJoint Research Unit IRTA-UAB in Animal Health, Animal Health Research Centre (CReSA), Autonomous University of Barcelona (UAB), Catalonia, Spain.ORCID 0000-0003-2935-928X
L LaordenDepartment of Immunology, Microbiology and Parasitology, Faculty of Pharmacy, MikroIker Research Group, University of the Basque Country (UPV/EHU), Vitoria-Gasteiz, Spain.ORCID 0000-0002-0538-7457
M J GrillóInstituto de Agrobiotecnología (IdAB; CSIC-Gobierno de Navarra), Mutilva, Navarra, Spain.ORCID 0000-0002-1819-0186
Gobierno de Navarra · ESUniversity of the Basque Country · ESUniversitat Autònoma de Barcelona · ES

Funding

Basque Country University (UPV/EHU) Grant PIF-19/290Centres de Recerca de Catalunya (CERCA) PA20/03Dirección General de Industria, Energia y Proyectos Estrategicos S3, Gobierno de Navarra (Department of Industry of the Government of Navarra) IIQ14061.RI1
6 · The paper itself

Abstract

The emergence of foodborne

Indexed as

Anti-Bacterial AgentsDrug Resistance, Multiple, BacterialInterspersed Repetitive SequencesPlasmidsSalmonellaAnimalsCephalosporin ResistanceCephalosporinsGene Transfer, HorizontalHumansSalmonella Infections, AnimalSpainSwineSwine DiseasesAnti-Bacterial AgentsCephalosporinscephalosporinsfoodbornemultidrug resistanceplasmidsSalmonellasequencingswine salmonellosis

Identifiers

PMID38695519
PMCPMC11107176
OpenAlexW4396581256

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.